Streetbeat News

Analyst Ratings

BFAM

Bright Horizons Family (BFAM) has been downgraded from buy to hold due to limited upside potential, despite strong fundamentals and growth. The company reported 11.4% revenue growth and a 25.5% increase in EPS, with a 10% growth outlook supported by strong demand.

Portfolio Pulse from

November 06, 2024 | 1:45 am

CVEO

Stonegate Capital Partners has updated their coverage on Civeo Corporation (CVEO), highlighting its consistent generation of positive free cash flow since 2014.

Portfolio Pulse from

November 05, 2024 | 10:30 pm

NCSM

Stonegate Capital Partners has updated their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) for the third quarter of 2024.

Portfolio Pulse from

November 05, 2024 | 9:45 pm

GOOD

Stonegate Capital Partners has updated its 3Q24 report on Gladstone Commercial Corp. (NASDAQ: GOOD), providing new insights and analysis on the company's performance.

Portfolio Pulse from

November 05, 2024 | 9:45 pm

ADBE

AVGO

GOOGL

The article recommends buying three tech giants with extensive AI applications: Alphabet Inc. (GOOGL), Adobe Inc. (ADBE), and Broadcom Inc. (AVGO). These companies are highlighted for their solid upside potential in the AI sector.

Portfolio Pulse from

November 05, 2024 | 8:15 pm

SYF

The article discusses strategies for investors to screen for stocks that combine impressive value with improving earnings outlooks, suggesting these as potential buys for November and beyond.

Portfolio Pulse from

November 05, 2024 | 8:15 pm

CORT

Corcept Therapeutics (CORT) is highlighted as a strong buy for growth investors due to its solid growth attributes, suggesting potential for exceptional returns.

Portfolio Pulse from

November 05, 2024 | 7:00 pm

EXEL

Exelixis (EXEL) is highlighted as a strong buy for growth investors due to its solid growth attributes, suggesting potential for exceptional returns.

Portfolio Pulse from

November 05, 2024 | 7:00 pm

MMSI

Merit Medical (MMSI) is highlighted as a solid growth stock with potential to outperform the market due to its strong growth attributes.

Portfolio Pulse from

November 05, 2024 | 7:00 pm

PEN

Penumbra (PEN) is recommended for growth investors due to its above-average financial growth, suggesting it is well-positioned to outperform the market.

Portfolio Pulse from

November 05, 2024 | 7:00 pm